Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 7;13(7):1087.
doi: 10.3390/biom13071087.

Exploration of Bis-Cinnamido-Polyamines as Intrinsic Antimicrobial Agents and Antibiotic Enhancers

Affiliations

Exploration of Bis-Cinnamido-Polyamines as Intrinsic Antimicrobial Agents and Antibiotic Enhancers

Melissa M Cadelis et al. Biomolecules. .

Abstract

The marine natural product ianthelliformisamine C is a bis-cinnamido substituted spermine derivative that exhibits intrinsic antimicrobial properties and can enhance the action of doxycycline towards the Gram-negative bacterium Pseudomonas aeruginosa. As part of a study to explore the structure-activity requirements of these activities, we have synthesized a set of analogues that vary in the presence/absence of methoxyl group and bromine atoms and in the polyamine chain length. Intrinsic antimicrobial activity towards Staphylococcus aureus, methicillin-resistant S. aureus (MRSA) and the fungus Cryptococcus neoformans was observed for only the longest polyamine chain examples of non-brominated analogues while all examples bearing either one or two bromine atoms were active. Weak to no activity was typically observed towards Gram-negative bacteria, with exceptions being the longest polyamine chain examples 13f, 14f and 16f against Escherichia coli (MIC 1.56, 7.2 and 5.3 µM, respectively). Many of these longer polyamine-chain analogues also exhibited cytotoxic and/or red blood cell hemolytic properties, diminishing their potential as antimicrobial lead compounds. Two of the non-toxic, non-halogenated analogues, 13b and 13d, exhibited a strong ability to enhance the action of doxycycline against P. aeruginosa, with >64-fold and >32-fold enhancement, respectively. These results suggest that any future efforts to optimize the antibiotic-enhancing properties of cinnamido-polyamines should explore a wider range of aromatic ring substituents that do not include bromine or methoxyl groups.

Keywords: antibiotics; antifungal agents; antimicrobial; indole; polyamine; potentiator; structure-activity relationships.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structures of antimicrobial marine natural products squalamine (1), ent-eusynstyelamide B (2), synoxazolidinone A (3) and ianthelliformisamine C (4).
Figure 2
Figure 2
Structures of cinnamic acid head groups 58.
Scheme 1
Scheme 1
Synthetic routes for the preparation of cinnamic acids 7 and 8. Reagents and conditions: (a) 1N NaOH, EtOH, reflux, N2, 4 h, 87% for 7; 86% for 8; (b) NaH, triethyl phosphonoacetate, rt, N2, 24 h, 68%.
Figure 3
Figure 3
Boc-protected polyamines 12af.
Scheme 2
Scheme 2
General method for the synthesis of target polyamine analogues 1316. Reagents and conditions: (a) Cinnamic acid (5) (2.2 equiv.), Boc-protected polyamine (12af) (1 equiv.), EDC·HCl/HOBt (2.6 equiv.), DIPEA (6 equiv.), CH2Cl2, rt, 20 h (yields 38–93%) or cinnamic acid (6–8) (2.2 equiv.), Boc-protected polyamine (12af) (1 equiv.), EDC·HCl (2.8 equiv.), DMAP (5 equiv.) and CH2Cl2, rt, 20 h (yields 26–88%); (b) TFA (0.2 mL) and CH2Cl2 (2 mL), N2, rt, 2 h (yields 27–92%).
Figure 4
Figure 4
Structures of 3-phenylpropanamido-polyamines 17 and 18.

References

    1. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for Bad Bugs: Confronting the Challenges of Antibacterial Discovery. Nat. Rev. Drug Discov. 2007;6:29–40. doi: 10.1038/nrd2201. - DOI - PubMed
    1. Singh S.B. Confronting the Challenges of Discovery of Novel Antibacterial Agents. Bioorg. Med. Chem. Lett. 2014;24:3683–3689. doi: 10.1016/j.bmcl.2014.06.053. - DOI - PubMed
    1. Carroll A.R., Copp B.R., Davis R.A., Keyzers R.A., Prinsep M.R. Marine Natural Products. Nat. Prod. Rep. 2023;40:275–325. doi: 10.1039/D2NP00083K. - DOI - PubMed
    1. Blunt J.W., Carroll A.R., Copp B.R., Davis R.A., Keyzers R.A., Prinsep M.R. Marine Natural Products. Nat. Prod. Rep. 2018;35:8–53. doi: 10.1039/C7NP00052A. - DOI - PubMed
    1. Barbosa F., Pinto E., Kijjoa A., Pinto M., Sousa E. Targeting Antimicrobial Drug Resistance with Marine Natural Products. Int. J. Antimicrob. Agents. 2020;56:106005. doi: 10.1016/j.ijantimicag.2020.106005. - DOI - PubMed

Publication types